The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index; none of the 2 sources its claims cite is checked for support yet.
BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.
Open accessAbstract
The BCL2 protooncogene encodes an inner mitochondrial membrane protein that blocks programmed cell death. BCL2 was isolated from the chromosomal breakpoint of follicular B-cell lymphoma. Transgenic mice that overexpress BCL2 display extended survival of resting B cells. In this study we use a monospecific anti-human BCL2 antibody to define the distribution of BCL2 protein within organized tissues. BCL2 is restricted within germinal centers to the follicular mantle and to portions of the light zone implicated in the selection and maintenance of plasma cells and memory B cells. BCL2 is present in the surviving T cells in the thymic medulla. All hematopoietic lineages that derive from a renewing stem cell also display BCL2. A limited number of nonlymphoid tissues demonstrate BCL2 and can be grouped as (i) glandular epithelium in which hormones or growth factors regulate hyperplasia and involution, (ii) complex differentiating epithelium such as skin and intestine characterized by long-lived stem cells, and (iii) long-lived postmitotic cells such as neurons. Within these tissues that demonstrate apoptotic cell turnover, BCL2 is often topographically restricted to long-lived or proliferating cell zones. BCL2's function as an antidote to apoptosis may confer longevity to progenitor and effector cells in these tissues.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Using a monospecific anti-human BCL2 antibody, the authors map BCL2 protein across organized tissues and find it topographically restricted to long-lived or proliferating zones in tissues with apoptotic turnover. BCL2 is present in selected lymphoid, hematopoietic, glandular epithelial, complex epithelial, and postmitotic neuronal compartments.
Key findings
- Within germinal centers, BCL2 is restricted to the follicular mantle and portions of the light zone implicated in selection and maintenance of plasma cells and memory B cells.
- BCL2 is present in surviving T cells in the thymic medulla and in all hematopoietic lineages derived from a renewing stem cell.
- A limited set of nonlymphoid tissues shows BCL2: glandular epithelium regulated by hormones/growth factors, complex differentiating epithelium such as skin and intestine with long-lived stem cells, and long-lived postmitotic cells such as neurons.
- In tissues with apoptotic cell turnover, BCL2 is often topographically restricted to long-lived or proliferating cell zones; the authors suggest BCL2 may confer longevity to progenitor and effector cells.
Methods
- The study uses a monospecific anti-human BCL2 antibody to define BCL2 protein distribution within organized tissues.
- The provided text does not report sample sizes, tissue sources, staining protocols, or quantitative analysis details.
Limitations
- The paper’s abstract does not state limitations.
- Evident from the provided text: only the abstract and reference list are available, so sample composition, antibody specificity controls, quantification, and full results cannot be assessed. No quantitative values are reported in the provided text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Own interpretation · 4 Own result · 2 No full text of the sources · 1 No basis given
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“All hematopoietic lineages that derive from a renewing stem cell also display BCL2.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BCL2 is present in the surviving T cells in the thymic medulla.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A limited number of nonlymphoid tissues demonstrate BCL2”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BCL2 is restricted within germinal centers to the follicular mantle and to portions of the light zone implicated in the selection and maintenance of plasma cells and memory B cells.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Within these tissues that demonstrate apoptotic cell turnover, BCL2 is often topographically restricted to long-lived or proliferating cell zones.”
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“glandular epithelium in which hormones or growth factors regulate hyperplasia and involution”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“long-lived postmitotic cells such as neurons”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
In the paper
“Transgenic mice that overexpress BCL2 display extended survival of resting B cells.”
What the sources say
- Not checked — no full text of the sourcecites McDonnell et al., 1989 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“complex differentiating epithelium such as skin and intestine characterized by long-lived stem cells”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BCL2's function as an antidote to apoptosis may confer longevity to progenitor and effector cells in these tissues.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
- It may state two separate claims as one. 1
In the paper
“The BCL2 protooncogene encodes an inner mitochondrial membrane protein that blocks programmed cell death.”
What the sources say
- Not checked — no full text of the sourcecites Hockenbery et al., 1990 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
The anti-human BCL2 antibody used in this study is monospecific for BCL2.
“we use a monospecific anti-human BCL2 antibody”
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,673
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Self-citationBcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D., Cory, S., & Adams, J. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,355
Cheng, H., & Leblond, C. P. (1974) · American Journal of Anatomy · doi:10.1002/aja.1001410407 · Cited by 1,737
Savill, J. S., Wyllie, A. H., Henson, J. E., Walport, M. J., Henson, P. M., & Haslett, C. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113970 · Cited by 1,536
Cohen, J., & Duke, R. C. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.1.38 · Cited by 1,406
Regressive Events in Neurogenesis
Cowan, W. M., Fawcett, J. W., O'Leary, D. D. M., & Stanfield, B. B. (1984) · Science · doi:10.1126/science.6474175 · Cited by 1,316
McDonnell, T. J., Deane, N., Platt, F. M., Nunez, G., Jaeger, U., McKearn, J. P., & Korsmeyer, S. J. (1989) · Cell · doi:10.1016/0092-8674(89)90174-8 · Cited by 1,213
Self-citationCleary, M. L., Smith, S. D., & Sklar, J. (1986) · Cell · doi:10.1016/0092-8674(86)90362-4 · Cited by 1,212
Bakhshi, A., Jensen, J. P., Goldman, P., Wright, J. J., McBride, O. W., Epstein, A. L., & Korsmeyer, S. J. (1985) · Cell · doi:10.1016/s0092-8674(85)80070-2 · Cited by 1,177
Self-citation
Cited by
Sorted by citations
Items 501–600 of 1,244
Gala, J., Vermylen, C., Cornu, G., et al. (1994) · Annals of Hematology · doi:10.1007/bf01757343 · Cited by 56
“The bcl-2 gene product has also been detected in celt lines [26] and in normal hematopoietic cells from lymphoid, erythroid, and myeloid lineages [21, 24 , 26, 32, 36-38] as well as in a wide range of hematological malignancies presenting neither karyotypic nor molecular evidence of bcl-2 rearrangement: chronic lympho…”
BackgroundKeen, J., Dixon, J. M., Miller, E. P., et al. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005796915388 · Cited by 56
Cutrona, G., Ulivi, M., Fais, F., et al. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.2.699 · Cited by 56
“Therefore, if the constitutive expression of c-myc predisposes the cell to either proliferation or apoptosis, then the bd-2 protooncogene system appears to dictate the outcome of the options imposed on the cell ( 50 , 51).”
BackgroundGommerman, J. L., & Berger, S. A. (1998) · Blood · doi:10.1182/blood.v91.6.1891 · Cited by 56
Dünker, N., Schmitt, K., Schuster, N., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.32991 · Cited by 55
The Action of Bax and Bcl-2 on T Cell Selection
Williams, O., Norton, T., Halligey, M., Kioussis, D., & Brady, H. J. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1125 · Cited by 54
The c-kit+ Maturation Pathway in Mouse Thymic T Cell Development: Lineages and Selection
Akashi, K., & Weissman, I. L. (1996) · Immunity · doi:10.1016/s1074-7613(00)80491-4 · Cited by 55
Mantegazza, R., Bernasconi, P., Confalonieri, P. A., et al. (1997) · Journal of Neurology · doi:10.1007/s004150050087 · Cited by 55
Differential Control of Cell Death in the Skin
Norris, D. A. (1995) · Archives of Dermatology · doi:10.1001/archderm.131.8.945 · Cited by 55
Xue, Y., Verhofstad, A. A. J., Lange, W., et al. (1997) · PubMed · Cited by 55
ZHAO, M., ZHANG, N., ECONOMOU, M., et al. (1994) · Histopathology · doi:10.1111/j.1365-2559.1994.tb01323.x · Cited by 55
Xiang, H., Wang, J., & Boxer, L. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01062-06 · Cited by 54
Kanai, T., Konno, H., Tanaka, T., Matsumoto, K., Baba, M., Nakamura, S., & Baba, S. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970529)71:5 · Cited by 41
Bcl-2, via Its BH4 Domain, Blocks Apoptotic Signaling Mediated by Mitochondrial Ras
Denis, G. V., Yu, Q., Ma, P., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210202200 · Cited by 54
Breuhahn, K., Mann, A., Müller, G., et al. (2000) · PubMed · Cited by 54
Grey, P., Chawla, P., Friedman, M., et al. (1997) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348949710600601 · Cited by 54
Lotem, J., & Sachs, L. (1994) · PubMed · Cited by 54
Role of Three Cancer ≪Master Genes≫ P53, Bcl2 and C-Myc on the Apoptotic Process
Chiarugi, V. P., & Ruggiero, M. (1996) · Tumori Journal · doi:10.1177/030089169608200303 · Cited by 54
Glick, S. H., Howell, L. P., & White, R. D. (1996) · The Journal of Urology · doi:10.1016/s0022-5347(01)66192-5 · Cited by 54
Role of Programmed Cell Death in Carcinogenesis
Isaacs, J. T. (1993) · Environmental Health Perspectives · doi:10.1289/ehp.93101s527 · Cited by 54
Differentiation and cell death: lessons from the immune system
Linette, G. P., & Korsmeyer, S. J. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90049-3 · Cited by 54
Self-citationYin, H., Okada, N., & Takagi, M. (2000) · Pathology International · doi:10.1046/j.1440-1827.2000.01091.x · Cited by 53
Branet, F., Brousset, P., Krajewski, S., et al. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.7.2726 · Cited by 53
Okayasu, I., Saegusa, M., Fujiwara, M., et al. (1995) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01213321 · Cited by 53
“Moreover, it has been reported that bcl-2 protein down-regulates apoptotic cell death resulting in longlived post-mitotic cells (Hockenbery et al. 1991; LeBrun et al. 1993).”
BackgroundClinical significance of bcl-2 gene expression in human breast cancer tissues
Kobayashi, S., Iwase, H., Ito, Y., et al. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005760013810 · Cited by 53
“categories: 1) glandular epithelium in which hormones or growth factors regulate hyperplasia and involution, 2) complex differentiation of epithelium such as skin and intestine characterized by longlived stem cells, and 3) long-lived post-mitotic cells such as neurons [4].”
BackgroundFunctional Aspects of Apoptosis in Hematopoiesis and Consequences of Failure
McKenna, S. L., & Cotter, T. G. (1997) · Advances in cancer research · doi:10.1016/s0065-230x(08)60098-6 · Cited by 53
Toda, I., Wickham, L. A., & Sullivan, D. A. (1998) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4466 · Cited by 52
Cerroni, L., & Kerl, H. (1994) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.1994.tb00279.x · Cited by 53
Gorczyca, W., Markiewski, M. M., Kram, A., et al. (1995) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00191359 · Cited by 53
Tanaka, M., Lee, K., Martínez‐Augustin, O., He, Y., Sanderson, I. R., & Walker, W. A. (1996) · Journal of Nutrition · doi:10.1093/jn/126.2.424 · Cited by 52
The Role of Immunohistochemistry in Idiopathic Chronic Intestinal Pseudoobstruction (CIPO)
Amiot, A., Cazals-Hatem, D. L., Joly, F., et al. (2009) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31819b381a · Cited by 52
“001 Colon Control 10 8±2 (6-10) 8±3 (6-13) NS 18±5 (15-30) 110±29 (90-125) <0.”
InfluentialExpression of bcl-2 in invasive and in situ carcinoma of the uterine cervix
Tjalma, W. A. A., Cuyperd, E. D., Weyler, J., et al. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70636-2 · Cited by 52
Dı́ez, J., Panizo, Á., Hernández, M., & Pardo, J. (1997) · Hypertension · doi:10.1161/01.hyp.29.3.776 · Cited by 52
T-B cell interaction inhibits spontaneous apoptosis of mature lymphocytes in Bcl-2-deficient mice.
Nakayama, K., Nakayama, K., Dustin, L. B., & Loh, D. Y. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.4.1101 · Cited by 52
“In the peripheral lymphoid system, immunization leads to the formation of germinal centers in which Bcl-2 expression ceases in dividing B cells that undergo somatic hypermutation (6, 11).”
Brenes, O., Vargas, F. A., Gätjens-Boniche, O., & Díaz, C. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.02.007 · Cited by 51
Young, R. L., & Korsmeyer, S. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3686-3697.1993 · Cited by 51
“intestine, skin, and several other tissues (25).”
BackgroundSelf-citationImmunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder.
Shiina, H., Igawa, M., Urakami, S., Honda, S., Shirakawa, H., & Ishibe, T. (1996) · Journal of Clinical Pathology · doi:10.1136/jcp.49.5.395 · Cited by 51
bcl‐2 protein expression is associated with better prognosis in colorectal cancer
Leahy, Mulcahy, H. E., O'Donoghue, & Parfrey (1999) · Histopathology · doi:10.1046/j.1365-2559.1999.00743.x · Cited by 51
Apoptosis in measles virus-infected human central nervous system tissues
McQuaid, S., McMahon, J. M., Herron, B. M., et al. (1997) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1997.8998089.x · Cited by 51
Xue, Y., Smedts, F. M. M., Verhofstad, A. A. J., et al. (1998) · PubMed · Cited by 51
Allgaier, B., Shi, M., Luo, D., & Koenig, J. M. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.331 · Cited by 51
“Several proto-oncogenes have also been implicated in the regulation of apoptosis in certain cells and tissues [49], with the best studied belonging to the bcl-2 gene family [50, 51].”
BackgroundHepatocyte death in hepatocarcinogenesis
Pitot, H. C. (1998) · Hepatology · doi:10.1002/hep.510280101 · Cited by 50
Li, J., Li, Q., Peng, Y., et al. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.03.033 · Cited by 50
2-Methoxy antimycin reveals a unique mechanism for Bcl-xL inhibition
Schwartz, P. S., Manion, M. K., Emerson, C. B., Fry, J. S., Schulz, C. M., Sweet, I. R., & Hockenbery, D. M. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0767 · Cited by 52
“in developing therapeutic inhibitors for Bcl-2–related survival proteins is the expression of these targets in many normal cell types (37, 38).”
BackgroundSelf-citationKato, Y., Morikawa, A., Sugiyama, T., Koide, N., Jiang, G. Z., Takahashi, K., & Yokochi, T. (1995) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1995.tb00192.x · Cited by 50
Expression of the protooncogene bcl-2 in Alzheimer's disease brain
O’Barr, S. A., Schultz, J. J., & Rogers, J. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02024-1 · Cited by 49
Bcl-2 proto-oncogene protein immunoreactivity in normally developing and axotomised rat retinas
Chen, S. T., Garey, L. J., & Jen, L. S. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90650-5 · Cited by 50
Miettinen, M., Sarlomo‐Rikala, M., & Kovatich, A. J. (1998) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050244 · Cited by 50
“Our findings are in agreement with previous investigators who found bcl-2 reactivity in peripheral nerves, ganglion cells and the myometrium [ 8 , 11].”
BackgroundResultExpression of bcl‐2 oncoprotein in renal cell tumours
Paraf, F., Gogusev, J., Chrétien, Y., et al. (1995) · The Journal of Pathology · doi:10.1002/path.1711770306 · Cited by 50
Handa, H., Hegde, U. P., Kotelnikov, V. M., et al. (1997) · Leukemia Research · doi:10.1016/s0145-2126(97)00006-4 · Cited by 49
Regulation of germ cell death in mammalian gonads
Matsui, Y. (1998) · Apmis · doi:10.1111/j.1699-0463.1998.tb01329.x · Cited by 49
Heidenreich, A., Schenkman, N. S., Sesterhenn, I. A., et al. (1998) · Apmis · doi:10.1111/j.1699-0463.1998.tb01324.x · Cited by 49
Expression of BCL-2 in primary breast cancer and its correlation with tumour phenotype
Nathan, B., Gusterson, B. A., Jadayel, D. M., et al. (1994) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058871 · Cited by 49
Bcl-2 expression and response to chemotherapy in colorectal adenocarcinomas
Schneider, H., Sampson, S. A., Cunningham, D., et al. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.70 · Cited by 49
Stattin, P. E., Damber, J., Karlberg, L., et al. (1996) · Urological Research · doi:10.1007/bf00304774 · Cited by 49
Adaptation and clonal selection models of castration‐resistant prostate cancer: Current perspective
Ahmed, M., & Li, L. (2012) · International Journal of Urology · doi:10.1111/iju.12005 · Cited by 50
Han, X., Liu, P., Liu, M., Wei, Z., Fan, S., Wang, X., Sun, S., & Chu, L. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000003 · Cited by 49
STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP
Spiotto, M. T., & Chung, T. D. (2000) · The Prostate · doi:10.1002/(sici)1097-0045(20000201)42:2 · Cited by 133
Craig, M. F. E., Swerdlow, S. H., & Cook, J. R. (2003) · American Journal of Clinical Pathology · doi:10.1309/820r-476k-y9g0-3l9a · Cited by 48
Hara, A., Hirose, Y., Wang, A., Yoshimi, N., Tanaka, T., & Mori, H. (1996) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00198341 · Cited by 48
IMMUNOHISTOCHEMICAL ANALYSIS OF BCL-2 PROTEIN EXPRESSION IN RENAL CELL CARCINOMA
HUANG, A., Fone, P. D., Gandour‐Edwards, R. F., et al. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(05)68635-1 · Cited by 48
Hyjek, E. M., Chadburn, A., Liu, Y. F., et al. (2001) · Blood · doi:10.1182/blood.v97.1.270 · Cited by 48
Immunoreactivity for bcl-2 protein in malignant mesothelioma and non-neoplastic mesothelium
Segers, K., Ramael, M., Kumar‐Singh, S., et al. (1994) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01069743 · Cited by 48
Szondy, Z., Molnár, P., Nemes, Z., et al. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00140-3 · Cited by 48
Differential Regulation of P53 and Bcl-2 Expression by Ultraviolet A and B
Wang, Y., Rosenstein, B. S., Goldwyn, S., Zhang, X., Lebwohl, M., & Wei, H. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00319.x · Cited by 48
Bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study
Schiffer, D., Cavalla, P., Migheli, A., et al. (1996) · Journal of Neuro-Oncology · doi:10.1007/bf00177472 · Cited by 48
“This is in line with the observation on differentiation of neuroblastomas [11] and with the association of bcl-2 expression and differentiation [6].”
BackgroundResultInfluentialKarp, S. L., Ortíz, A., Li, S., et al. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5286 · Cited by 48
Greenberg, E. F., Lavik, A. R., & Distelhorst, C. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.03.008 · Cited by 47
Magal, S. S., Jackman, A., Ish-Shalom, S., Edry‐Botzer, L., Gonen, P., Schlegel, R., & Sherman, L. (2005) · Journal of General Virology · doi:10.1099/vir.0.80453-0 · Cited by 47
“Bcl-2, a suppressor protein of apoptosis, is expressed exclusively in the undifferentiated basal layer of the epithelium (Hockenbery et al., 1991; Polakowska et al., 1994; Jordan et al., 1996), while expression of Bax, a pro-apoptotic protein, is increased in the suprabasal layers (Jordan et al.,…”
Brunner, C., Marinković, D., Klein, J., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022014 · Cited by 47
“Bcl2 expression is diminished or absent in germinal centers (25, 26).”
BackgroundApoptosis in the development of the immune system: Growth factors, clonal selection and bcl-2
McCarthy, N. J., Smith, C. A., & Williams, G. T. (1992) · Cancer and Metastasis Reviews · doi:10.1007/bf00048062 · Cited by 46
Krishna, M., Smith, T. W., & Recht, L. D. (1995) · Journal of neurosurgery · doi:10.3171/jns.1995.83.6.1017 · Cited by 47
Othman, N., In, L. L. A., Harikrishna, J. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081735 · Cited by 46
“The expression level of bcl-2 differs between various cell types, however high levels and aberrant patterns of bcl-2 expression have been reported in a wide variety of human cancers [2].”
BackgroundVargas, F. A., Gätjens-Boniche, O., Vargas-Méndez, E., Valverde, B., & Díaz, C. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.06.047 · Cited by 46
Liang, G.-B., Wei, J.-H., Jiang, H., Huang, R.-Z., Qin, J.-T., Wang, H., Wang, H., & Zhang, Y. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112951 · Cited by 48
UV irradiation induces downregulation of bcl-2 expression in vitro and in vivo
Isoherranen, K., Sauroja, I., Jansén, C. T., & Punnonen, K. R. A. (1999) · Archives of Dermatological Research · doi:10.1007/s004030050396 · Cited by 46
Shabnam, M. S., Srinivasan, R., Wali, A., Majumdar, S., Joshi, K., & Behera, D. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.01.021 · Cited by 46
Stoebner, Carayon, Penarier, et al. (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02896.x · Cited by 46
Genetic aspects of prostate cancer
Latil, A., & Lidereau, R. (1998) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050183 · Cited by 43
Nagy, L., Thomázy, V. A., Chandraratna, R. A. S., Heyman, R. A., & Davies, P. J. (1996) · Leukemia Research · doi:10.1016/0145-2126(95)00118-2 · Cited by 46
Bubendorf, L., Sauter, G., Moch, H., Schmid, H., Gasser, T. C., Jordan, P., & Mihatsch, M. J. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199604)178:4 · Cited by 201
Peyer's Patches as Inductive Sites for IgA Commitment
Cebra, J. J., & Shroff, K. E. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-524730-6.50018-x · Cited by 46
Reichenbach, A., Stolzenburg, J. ‐., Wolburg, H., et al. (1995) · Glia · doi:10.1002/glia.440130306 · Cited by 45
Staibano, S., Mignogna, M. D., Muzio, L. L., et al. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90244-1 · Cited by 45
Bcl‐2 proto‐oncogene expression in low‐ and high‐grade prostatic intraepithelial neoplasia
Baltacı, S., Orhan, D., Özer, G., Tolunay, Ö., & üs, O. G. (2000) · British Journal of Urology · doi:10.1046/j.1464-410x.2000.00388.x · Cited by 43
Molecular and biological factors in the prognosis of non-small cell lung cancer
Kanters, S., Lammers, J. J., & Voest, E. E. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08081389 · Cited by 45
Redistribution of Activated Caspase-3 to the Nucleus during Butyric Acid-Induced Apoptosis
Mandal, M., Adam, L., & Kumar, R. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0966 · Cited by 45
Apoptosis of colon cancer: Comparison with Ki-67 proliferative activity and expression of p53
Takano, Y., Saegusa, M., Ikenaga, M., Mitomi, H., & Okayasu, I. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01366957 · Cited by 45
“1991), bcl-2 (Hockenbery et al. 1991) and c-myc (Shi et al.”
Nishimura, A. (1999) · Journal of Dental Research · doi:10.1177/00220345990780061101 · Cited by 45
Bcl-2 and Bax expression in thyroid tumours An immunohistochemical and Western blot analysis
Manetto, V., Lorenzini, R., Cordon‐Cardo, C., et al. (1997) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01008033 · Cited by 45
Alfandari, J., Magal, S. S., Jackman, A., et al. (1999) · Virology · doi:10.1006/viro.1999.9675 · Cited by 45
bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status
Newcomb, E. W., Bhalla, S. K., Parrish, C. L., et al. (1997) · Acta Neuropathologica · doi:10.1007/s004010050721 · Cited by 45
“Tonsil sections, used as a positive control, showed numerous lymphocytes with cytoplasmic staining for bcl-2 in T cell areas and the mantle zone, but no immunopositive cells within germinal centers, as has been described previously [ 13 , 18].”
BackgroundResultInfluentialMolecular study of sex steroid receptor gene expression in human colon and in colorectal carcinomas
Waliszewski, P., Blaszczyk, M., Wolińska‐Witort, E., Drews, M., Snochowski, M., & Hurst, R. E. (1997) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(199701)64:1 · Cited by 56
Lestou, V. S., Gascoyne, R. D., Sehn, L. H., et al. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04502.x · Cited by 45
“The t(14;18) induces deregulated expression of the BCL2 gene, but additional mutations are required to establish a fully malignant phenotype (Hockenbery et al, 1991; McDonnell et al, 1993).”
BackgroundHormone-refractory prostate cancer: a multi-step and multi-event process
TAILLE, A. D. L., Vacherot, F., Salomon, L., Druel, C., de Medina, S. G. D., Abbou, C. C., Buttyan, R. E., & Chopin, D. K. (2001) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500534 · Cited by 45
Tsamandas, A. C., Thomopoulos, K., Zolota, V., et al. (2003) · Modern Pathology · doi:10.1097/01.mp.0000097367.56816.5e · Cited by 44
Ne, G., Jones, M., Turley, H., et al. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.5.447 · Cited by 44
Glomerular cell proliferation and apoptosis in uninephrectomized spontaneously hypertensive rats
Rodrı́guez-López, A. M., Flores, O., Arévalo, M. A., & López-Novoa, J. M. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.06810.x · Cited by 44
Mita, M. M., Ochoa, L., Rowinsky, E. K., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdj067 · Cited by 44
Foster, C. S., Dodson, A. R., Karavana, V. N., et al. (2002) · The Journal of Pathology · doi:10.1002/path.1194 · Cited by 44
Metadata
- Authors
- Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., & Korsmeyer, S. J.
- Affiliations
- Washington University in St. Louis (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1991-08-15
- Volume
- 88
- Issue
- 16
- Pages
- 6961-6965
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC52213
- OpenAlex
- W1970629830
- Semantic Scholar
- d825dc162ad208c572711f59c9aa1c7974e89492
- Cited by
- 1,252
- References
- 40
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 9 · 2022: 4 · 2021: 5 · 2020: 10 · 2019: 9 · 2018: 9 · 2017: 9 · 2016: 7 · 2015: 10 · 2014: 15 · 2013: 10 · 2012: 12
- FWCI
- 26.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- Bcl-2, apoptosis, germinal center, light zone, plasma cells, memory B cells, thymic medulla, hematopoietic stem cells, tissue distribution, epithelial stem cells, follicular B-cell lymphoma, transgenic mice
- MeSH terms
- Adult, Bone Marrow, Breast, Cell Survival, Digestive System, Female, Humans, Immunoenzyme Techniques, Male, Neurons, Pancreas, Prostate, Protein-Tyrosine Kinases, Proto-Oncogene Proteins, Proto-Oncogenes, Skin, Thymus Gland, Palatine Tonsil, Proto-Oncogene Proteins c-bcl-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
